Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.59 |
| ▸ | DPP4 | P27487 | 1/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31657795 | 0.96 | ACE (0.55) | ACEDPP4ACE2 | |
| SCHEMBL29589468 | 0.91 | ACE (0.71) | ACEDPP4ACE2 | |
| SCHEMBL30533415 | 0.88 | OPRM1 (0.53) | — | |
| SCHEMBL31683327 | 0.85 | OPRM1 (0.50) | — | |
| SCHEMBL30116349 | 0.85 | OPRM1 (0.50) | — | |
| SCHEMBL30503063 | 0.85 | SLC6A2 (0.53) | — | |
| SCHEMBL9053553 | 0.85 | SLC6A2 (0.63) | — | |
| SCHEMBL9052421 | 0.85 | SLC6A2 (0.63) | — | |
| SCHEMBL29725118 | 0.84 | OPRD1 (0.51) | — | |
| SCHEMBL14865143 | 0.83 | OPRD1 (0.52) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3121 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12214059-B2 | Cleavable radioligands for targeting cell surface receptors and uses thereof | FULL-LIFE TECHNOLOGIES HK LIMITED (CN) | 2025-02-04 | — | — | US | claimed |
| EP-3720480-B1 | PHENOTYPIC MARKERS FOR CELL THERAPY AND RELATED METHODS | JUNO THERAPEUTICS INC (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-108290931-B | Novel polypeptides having affinity for PD-L1 | AFFIBODY AB (SE) | 2026-05-26 | — | — | CN | disclosed |
| CN-116355945-B | Application of MYB3R1 gene in regulation and control of root nodule number of nodule plant | Center for excellence and innovation in molecular plant science, Chinese Academy of Sciences (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-115038722-B | Antibodies against KLK5 | UCB biopharmaceutical Co.,Ltd. (BE) | 2026-05-26 | — | — | CN | disclosed |
| CN-115925917-B | Anti-PVRIG protein antibodies or antibody fragments and uses thereof | 合肥天港免疫药物有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-116583298-B | PD-1 targeted IL-15/IL-15RαFC fusion proteins with improved properties | 基因泰克公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260125449-A1 | ARTICLES OF MANUFACTURE AND METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY | JUNO THERAPEUTICS, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12617971-B2 | Anti-viral coating composition, and method for fixing anti-viral fusion protein to surfaces | AMOLIFESCIENCE CO., LTD. (KR) | 2026-05-05 | — | — | US | disclosed |
| US-20260115287-A1 | T CELL THERAPY IN PATIENTS WHO HAVE HAD PRIOR STEM CELL TRANSPLANT | CELGENE CORPORATION (US) | 2026-04-30 | — | — | US | disclosed |
| CN-113993547-A | Use of bispecific antigen binding molecules that bind MUC16 and CD3 in combination with 4-1BB co-stimulation | 瑞泽恩制药公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993900-A | Antibody specifically recognizing nerve growth factor and use thereof | 舒泰神（北京）生物制药股份有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993989-A | Process for producing ergothioneine | 丹麦科技大学 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993541-A | Alkaline phosphatase-based oncology therapy | 合成生物制品有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113968911-A | insulin-Fc fusion protein and application thereof | 江苏晟斯生物制药有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-109563449-B | Use of enzymes, compositions and methods for removing soils | 诺维信公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113960313-A | Exosome ALK fusion protein magnetic immunochemiluminescence detection kit | 上海思路迪医学检验所有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-107847592-B | Antibodies against human CSF-1R for inducing lymphocytosis in lymphomas or leukemias | 豪夫迈·罗氏有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957088-A | Artificial design and application of intercellular communication system | 中国科学院微生物研究所 | 2022-01-21 | — | — | CN | disclosed |
| CN-113956990-A | Recombinant saccharomyces cerevisiae for producing dihydronilotinib as well as preparation method and application thereof | 中国中医科学院中药研究所 | 2022-01-21 | — | — | CN | disclosed |